The role of miR-429 in cancer: From biogenesis, signaling pathways, interactions with long non-coding RNAs, and function to therapeutic application.

in Critical reviews in oncology/hematology by Ensiyeh Bahadoran, Abouzar Babaei, Reza Ranji, Parisa Badameh, Samira Sabzi, Babak Rahmani, Hadi Ebadi

TLDR

  • miR-429 is a critical regulator of gene expression, influencing cancer biology and tumorigenesis.
  • The study highlights its diverse expression patterns and dual role in tumorigenesis and metastasis.
  • miR-429 may serve as a valuable biomarker and therapeutic target for cancer diagnosis and treatment.

Abstract

MicroRNAs (miRNAs) have emerged as critical regulators of gene expression, playing pivotal roles in cancer biology. Among these, miR-429, a member of the miR-200 family, influences migration, metastasis, apoptosis, and cell proliferation, all of which are vital for controlling cancer biology. This review examined the biogenesis, regulation, and signaling pathways associated with miR-429, as well as its interactions with long non-coding RNAs (lncRNAs) and other molecular networks that contribute to tumorigenesis. We explore its diverse expression patterns across various malignancies, including renal cell carcinoma, esophageal cancer, breast cancer, lung cancer, and glioblastoma, highlighting its dual role in tumorigenesis and metastasis. Additionally, it addresses the clinical relevance of miR-429, assessing its potential as a biomarker for cancer diagnosis, prognosis, and its promising therapeutic implications. Through a detailed analysis of miR-429 expression patterns and their impact across different cancer types, this review highlights its complex mechanisms in different cancers and its potential for targeted cancer therapy.

Overview

  • The study focuses on the role of microRNA-429 (miR-429) in cancer biology, examining its biogenesis, regulation, and signaling pathways, as well as its interactions with long non-coding RNAs (lncRNAs) and other molecular networks.
  • The study aims to explore the diverse expression patterns of miR-429 across various malignancies, including renal cell carcinoma, esophageal cancer, breast cancer, lung cancer, and glioblastoma, highlighting its dual role in tumorigenesis and metastasis.
  • The study assesses the clinical relevance of miR-429, evaluating its potential as a biomarker for cancer diagnosis, prognosis, and its promising therapeutic implications.

Comparative Analysis & Findings

  • The study found that miR-429 plays a complex role in different cancers, with diverse expression patterns across various malignancies.
  • The study identified miR-429 as a powerful regulator of gene expression, influencing migration, metastasis, apoptosis, and cell proliferation.
  • The study highlights the dual role of miR-429 in tumorigenesis and metastasis, with potential implications for targeted cancer therapy.

Implications and Future Directions

  • The study suggests that miR-429 may serve as a valuable biomarker for cancer diagnosis and prognosis, with potential therapeutic applications in targeted cancer therapy.
  • Future studies should investigate the specific mechanisms of miR-429 regulation in different cancers and explore its potential as a therapeutic target.
  • The study paves the way for further research on the role of miR-429 in cancer biology, exploring its complex mechanisms and potential therapeutic implications.